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Craig Rogers, MD. Vattikuti Urology Institute, Henry Ford Health System, Detroit, MI 48202
In this inaugural point/counterpoint of controversial topics in robotic surgery, the authors
both make convincing arguments for their preferred approach for robotic
prostatectomy. Dr. Crivellaro gives a nice perspective on the evolution of the procedure
and makes a cogent argument for advantages of an extraperitoneal (EP) approach and that
the single-port (SP) robot can facilitate the EP approach. Dr. Abaza gives a practical
response in support of an intraperitoneal (IP) approach. His published outcomes speak for
themselves and he is also able to achieve benefits with the SP robot using an IP approach,
supporting that surgeon experience and technique are more important than approach. As
with many things in surgery, there’s usually no absolute right or wrong, but rather what
works best for the surgeon to do the best job possible. EP may have theoretical
advantages, but surgeons should not feel pressured that they must do an EP approach or
use the SP robot in order to provide standard of care. Will availability of the SP robot
potentially encourage more surgeons to adopt an EP approach? Perhaps, but this remains
to be seen over time. Surgeons may want to consider expanding their skill set to include EP
approach and SP so they have more tools in their toolbox in order to adapt to specific
clinical situations. On the other hand, surgeons should not feel pressured to adopt an EP
approach just because it is new and trendy or because an SP robot is available. Surgeons
may prefer approaches that seem more reproducible, familiar, and with a longer track
record and may take the approach “If it ain’t broke, don’t fix it”. But surgery and
technology continues to evolve, and when technological advances make an approach
easier, more surgeons may consider adopting. When learning any new technique, patient
selection is key. During my own learning curve for EP robotic prostatectomy using the SP
robot, I found it useful to carefully select patients with smaller prostates (<50gm), lower
risk disease (no extended lymph node dissection), and lower BMI. But with increasing
experience, selection can be broadened. In the end, we use the tools and techniques that
work best for us to do our best for our patients. We look forward to providing more
point/counterpoint pieces on controversial topics in robotic surgery in the future.

